NK-1 receptor active amine oxide prodrugs
US6747026B2 · kind B2 · utility
11Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2003 |
| Grant date | Jun 8, 2004 |
| Priority date | — |
| Expiry date | Mar 14, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.